BNP Paribas Financial Markets’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-140
| Closed | -$210 | – | 3349 |
|
|
2023
Q1 | $210 | Sell |
140
-545
| -80% | -$818 | ﹤0.01% | 3127 |
|
|
2022
Q4 | $684 | Buy |
685
+545
| +389% | +$544 | ﹤0.01% | 3177 |
|
|
2022
Q3 | $252 | Sell |
140
-2,761
| -95% | -$4.97K | ﹤0.01% | 3875 |
|
|
2022
Q2 | $8.41K | Sell |
2,901
-91,594
| -97% | -$266K | ﹤0.01% | 3124 |
|
|
2022
Q1 | $261K | Sell |
94,495
-37,400
| -28% | -$103K | ﹤0.01% | 2479 |
|
|
2021
Q4 | $615K | Buy |
131,895
+124,064
| +1,584% | +$578K | ﹤0.01% | 2301 |
|
|
2021
Q3 | $66.6K | Buy |
7,831
+4,375
| +127% | +$37.2K | ﹤0.01% | 2839 |
|
|
2021
Q2 | $56.7K | Sell |
3,456
-19,808
| -85% | -$325K | ﹤0.01% | 2630 |
|
|
2021
Q1 | $514K | Buy |
23,264
+19,672
| +548% | +$434K | ﹤0.01% | 2029 |
|
|
2020
Q4 | $111K | Sell |
3,592
-2,419
| -40% | -$74.8K | ﹤0.01% | 2512 |
|
|
2020
Q3 | $122K | Buy |
6,011
+5,359
| +822% | +$109K | ﹤0.01% | 2396 |
|
|
2020
Q2 | $10K | Sell |
652
-2,965
| -82% | -$45.5K | ﹤0.01% | 3079 |
|
|
2020
Q1 | $28K | Buy |
3,617
+904
| +33% | +$7K | ﹤0.01% | 3195 |
|
|
2019
Q4 | $38.7K | Buy |
2,713
+1,370
| +102% | +$19.6K | ﹤0.01% | 3116 |
|
|
2019
Q3 | $20.2K | Buy |
1,343
+1,265
| +1,622% | +$19K | ﹤0.01% | 3303 |
|
|
2019
Q2 | $1.12K | Buy |
+78
| New | +$1.12K | ﹤0.01% | 3736 |
|